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VZV IN BIOPSY-POSITIVE AND -NEGATIVE GIANT
CELL ARTERITIS: ANALYSIS OF 1001
TEMPORAL ARTERIES
We report the cumulative frequency, including previ-
ous studies,1,2 showing varicella-zoster virus (VZV)
antigen in 73/104 (70%) giant cell arteritis (GCA)–
positive temporal arteries (TAs), in 58/100 (58%)
GCA-negative TAs (patients who manifest clinical
and laboratory features of GCA whose TA biopsies
are pathologically negative for GCA) and in 11/61
(18%) normal TAs acquired at autopsy. The location
of VZV antigen in specific arterial layers and patho-
logic findings in GCA-negative arteries helps to
explain disease pathogenesis.
Methods. De-identified formalin-fixed, paraffin-
embedded TA biopsies were obtained from
participants .50 years of age. Of 204 TAs, 104
were GCA-positive and 100 were GCA-negative.
Age and sex were available for 96 GCA-positive
TAs, 36 (37%) of which were in men and 60
(63%) in women, age 51–89 years. Of 100
GCA-negative TAs, age and sex data were available
for 95 TAs, 40 (42%) of which were in men and 55
(58%) in women, age 50–89 years. Sixty-one
control TAs were removed postmortem from age-
matched participants. All TAs were examined
immunohistochemically as described.1 Location of
viral antigen in adventitia, media, or intima was
documented. VZV antigen-positive sections from
58 GCA-positive TAs, 58 GCA-negative TAs, and
11 normal TAs were analyzed for VZV DNA as
described.1
Sections 5 mm adjacent to those containing VZV
antigen were stained with hematoxylin & eosin. If a
GCA-negative TA section appeared to contain
inflammatory cells, it was destained and immunos-
tained with rabbit anti-CD45 as described.2
Results. Immunohistochemical analysis revealed
VZV antigen in 73/104 (70%) GCA-positive and
58/100 (58%) GCA-negative TAs compared to
11/61 (18%) normal TAs. VZV antigen was 3.89-
fold more likely to be present in GCA-positive TAs
than in normal TAs (95% confidence interval [CI]
2.3819, 7.2384, p , 0.0001) and 3.22 times more
likely to be present in GCA-negative TAs than in
normal TAs (95% CI 1.9391, 6.0303, p , 0.0001).
All TAs contained viral antigen in multiple arterial
layers (figure, A–F). In GCA-positive and GCA-
negative TAs, viral antigen was seen in the adventitia
(86% and 95%, respectively), media (67% and 53%,
respectively), and intima (52% and 45%, respec-
tively); in normal TAs, viral antigen was seen in the
adventitia (91%) and equally in media (82%) and
intima (82%).
Of 58 GCA-positive, VZV antigen–positive TAs
examined, all contained cellular DNA and 23 (40%)
contained VZV DNA. Of 58 GCA-negative, VZV
antigen–positive TAs examined, 51 contained cellular
DNA, 9 (18%) of which contained VZV DNA. Nine
of 11 normal VZV antigen-positive TAs contained
cellular DNA, of which 3 (33%) contained VZV
DNA.
Adventitial inflammation was seen adjacent to
viral antigen in 26 (52%) of 58 GCA-negative par-
ticipants whose TAs contained VZV antigen (fig-
ure, G–L). No inflammation was seen in normal
TAs containing VZV antigen.
Discussion. Detection of VZV in 73/104 GCA-
positive TAs (70%) and 58/100 GCA-negative TAs
(58%) compared to 11/61 normal TAs (18%) was
highly statistically significant (p , 0.0001). Despite
formalin fixation, VZVDNAwas detected by PCR in
many VZV antigen–positive sections. Detection of
VZV antigen without inflammation in normal TAs
indicates that VZV reactivates subclinically in some
people over age 50 years. The greater frequency of
VZV in the adventitia than in media and intima in all
groups most likely reflects transaxonal transport of
virus along afferent nerve fibers that innervate the
TA after reactivation from ganglia.
VZV antigen and inflammation was usually
patchy and detected in only some, but not all sec-
tions. Our exhaustive, research-focused evaluation is
not practical for routine diagnostic work-up of TA
biopsies. Immunohistochemical evaluation is worth-
while, but a negative result should cite possible short-
falls: specifically, a negative biopsy does not rule out
GCA or VZV reactivation.
Detection of adventitial inflammation adjacent to
VZV antigen in 52% of GCA-negative TAs for the
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first time connects the presence of VZV with
pathology in GCA-negative TAs. Inflammation
restricted to the adventitia may represent a milder
form of GCA3 and has also been associated with
ischemic optic neuropathy (ION).4,5 Interestingly,
we initially detected VZV in a TA from a patient
with ION whose biopsy revealed both adventitial
and intimal inflammation but not classic GCA.6
Overall, finding VZV mostly in the adventitia of
GCA-positive TAs and VZV with inflammation in
the adventitia of GCA-negative TAs indicates that
inflammation follows VZV reactivation from
ganglia and transaxonal transport to arterial adven-
titia. The tempo and evolution of GCA (transmu-
ral inflammation and necrosis with giant or
epithelioid cells) after virus infection of the
Figure Varicella-zoster virus (VZV) antigen in giant cell arteritis (GCA)–positive and GCA-negative temporal
arteries (TAs) and inflammation adjacent to VZV antigen in GCA-negative TAs
VZV antigen in TAs of GCA-positive and GCA-negative patients (clinical and laboratory features of GCA whose TA biopsies
were pathologically negative for GCA) was detected immunohistochemically using mouse anti-VZV gE immunoglobulin (Ig)
G1 antibody (Santa Cruz Biotechnology, Dallas, TX; catalog no. SC-56995). After immunostaining with primary and biotiny-
lated secondary antibodies, slides were treated with prediluted streptavidin-alkaline phosphatase (BD Biosciences, San Die-
go, CA) for 1 hour. The color reaction was developed under a light microscope using the fresh fuchsin substrate system
(Dako, Carpinteria, CA) with levamisole (Dako; 24 mg/mL). VZV antigen is shown in the adventitia of a positive control
VZV-infected cadaveric cerebral artery 14 days after infection in vitro (A), in the adventitia and media of a GCA-positive
TA (B), and in the media and intima of a GCA-negative TA (C). No staining was seen when mouse isotype IgG1 was
substituted for primary mouse anti-VZV gE IgG1 antibody (D–F). In GCA-negative TAs, hematoxylin & eosin (H&E) staining
of TA sections adjacent to those containing VZV antigen revealed inflammatory cells (G, J, arrows) identified as CD45-
positive (H, K, pink) after destaining H&E sections and immunostaining with rabbit anti-CD45 antibody (Abcam, Cambridge,
MA; catalog no. AB10558). No staining was seen when normal rabbit serum was substituted for rabbit anti-CD45 antibody
(I, L). 6003 magnification.
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adventitia and adventitial inflammation remains to
be determined.
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